Evidence map›Paper›PMID 38170739›Full record

ArticleBlood advances2024

A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML.

Zhibo Zhang, Jia Yin, Guoli Lian, Xiebing Bao, Meng Hu, Zhenfang Liu, Yuan Yu, Ruihua Mi, Yabei Zuo, Pengcheng Shi and 11 more

Abstract readComparative StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Zhibo ZhangNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.ORCID 0000-0002-8204-5549
Jia YinNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.ORCID 0000-0002-4228-406X
Guoli LianDepartment of Pediatrics, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xiebing BaoNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Meng HuDepartment of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhenfang LiuDepartment of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yuan YuDepartment of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Ruihua MiDepartment of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Yabei ZuoDepartment of Hematology, Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, China.
Pengcheng ShiDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Weiyan ZhengBone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Qian JiangPeking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Hongying ChaoDepartment of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, China.
Peifang XiaoDepartment of Hematology, Children's Hospital of Soochow University, Suzhou, China.
Weijuan YuDepartment of Hematology Laboratory, Yantai Yuhuangding Hospital, Yantai, China.
Yanqiu HanDepartment of Hematology, Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.ORCID 0000-0002-2658-0803
Yu WuDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Yan ZengDepartment of Hematology, Chengdu Second People's Hospital, Chengdu, China.
Depei WuNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.ORCID 0000-0002-6312-3863
Xiaofei YangNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Suning ChenNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.ORCID 0000-0001-6294-972X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteMastocytosis, SystemicHumansMutationRetrospective Studies

Identifiers

PMID38170739
PMCPMC10875270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.